Annual fees related to agreement.

No definition available.

Name:	sgmo_AnnualFeesRelatedToAgreement
Namespace Prefix:	sgmo_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Collaboration agreement related costs and expenses.

+ References

No definition available.

+ Details

Name:	sgmo_CollaborationAgreementRelatedCostsAndExpenses
Namespace Prefix:	sgmo_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Fee due.

+ References

No definition available.

+ Details

Name:	sgmo_FeeDue
Namespace Prefix:	sgmo_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Initial research term of agreement.

+ References

No definition available.

+ Details

Name:	sgmo_InitialResearchTermOfAgreement
Namespace Prefix:	sgmo_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Milestone payment and royalty revenue of previous agreement.

+ References

No definition available.

+ Details

Name:	sgmo_MilestonePaymentAndRoyaltyRevenueOfPreviousAgreement
Namespace Prefix:	sgmo_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Minimum sublicense annual fees specific reckoning period.

+ References

No definition available.

+ Details

Name:	sgmo_MinimumSublicenseAnnualFeesSpecificReckoningPeriod
Namespace Prefix:	sgmo_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

One time license fee earned.

+ References

No definition available.

+ Details

Name:	sgmo_OneTimeLicenseFeeEarned
Namespace Prefix:	sgmo_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Percentage of royalties to be received from sublicensing.

+ References

No definition available.

+ Details

Name:	sgmo_PercentageOfRoyaltiesToBeReceivedFromSublicensing
Namespace Prefix:	sgmo_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Revenue earned during the period relating to consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity.

+ References

+ Details

Name:	us-gaap_LicensesRevenue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Revenue earned during the period from the leasing or otherwise lending to a third party the entity's rights or title to certain property. Royalty revenue is derived from a percentage or stated amount of sales proceeds or revenue generated by the third party using the entity's property. Examples of property from which royalties may be derived include patents and oil and mineral rights.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(e))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

+ Details

Name:	us-gaap_RoyaltyRevenue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=us-gaap_LicenseAgreementTermsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_CounterpartyNameAxis=sgmo_DowAgroSciencesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Major Customers, Partnerships and Strategic Alliances - Agreement with Dow AgroSciences in Plant Agriculture - Additional Information (Detail) - License agreement terms [Member] - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended
	Oct. 31, 2005	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Collaboration agreement related costs and expenses		$ 0	$ 700,000	$ 200,000	$ 1,000,000
Dow Agro Sciences [Member]
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Research program to develop laboratory research reagents	3 years
One-time license fee earned on exercise of option	$ 6,000,000
Royalty revenues	$ 2,300,000
Percentage of royalties to be received from sublicensing	25.00%
Previously agreed research, development and commercialization milestone payments, and royalties on sales of products	$ 4,000,000
Fee due	$ 25,300,000
Minimum license annual fees specific reckoning period	11 years
Collaboration agreement related costs and expenses		0	0	0	0
Revenue attributable to research and development		$ 0	$ 0	$ 0	$ 0
Dow Agro Sciences [Member] \| Minimum [Member]
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Annual fees	$ 250,000
Dow Agro Sciences [Member] \| Maximum [Member]
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Annual fees	$ 3,000,000